Filing Details
INTERPACE BIOSCIENCES, INC. (OTC:IDXG) filed a Form 8-K with the Securities and Exchange Commission on October 15, 2026, disclosing a material event.
8k filedOTC:IDXG
INTERPACE BIOSCIENCES, INC. (IDXG) Reports Material Event to SEC
INTERPACE BIOSCIENCES, INC. (OTC:IDXG) filed a Form 8-K with the Securities and Exchange Commission on October 15, 2026, disclosing a material event.
At publication ·
What changed
INTERPACE BIOSCIENCES, INC. (OTC:IDXG) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- INTERPACE BIOSCIENCES, INC. (IDXG) filed a Form 8-K on October 15, 2026, disclosing a material event to shareholders.
- The stock trades at $5.27 with a market capitalization of $6.6 million.
- The article does not specify the nature of the material event, only that it was disclosed through the standard 8-K filing process.
Market Context
INTERPACE BIOSCIENCES, INC.'s stock currently trades at $5.27 with a market capitalization of $6.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for INTERPACE BIOSCIENCES, INC.'s stock.
All SEC filings for INTERPACE BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IDXG Stock Page
Frequently Asked Questions
Where can I read IDXG's SEC filings?
Browse all filings on our IDXG SEC filings page.
What types of SEC filings does INTERPACE BIOSCIENCES, INC. file?
Public companies like INTERPACE BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
